Insider · CIK 0001613482

Ticktin Robert

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001613482

Forms 4 and 5

Insider transactions

13 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	General Counsel & COO	AAward	+319K sh	—	—	319,270
2025-07-01	PMVPPMV Pharmaceuticals, Inc.S Sale	General Counsel & COO	SSale	−23.2K sh	$1.06	−$24.7K	98,695
2016-05-27	EPIRUS Biopharmaceuticals, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+230K sh	—	—	230,000
2016-02-27	EPIRUS Biopharmaceuticals, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+949 sh	—	—	3,949
2016-02-27	EPIRUS Biopharmaceuticals, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+2,134 sh	—	—	6,083
2016-02-27	EPIRUS Biopharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−949 sh	—	—	0
2016-02-27	EPIRUS Biopharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−2,134 sh	—	—	6,400
2015-12-21	EPIRUS Biopharmaceuticals, Inc.P Purchase	General Counsel	PPurchase	+3,000 sh	$3.72	+$11.2K	3,000
2015-11-02	EPIRUS Biopharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+39.5K sh	—	—	39,474
2015-02-27	EPIRUS Biopharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+65K sh	—	—	65,006
2015-02-27	EPIRUS Biopharmaceuticals, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+949 sh	—	—	949
2015-02-27	EPIRUS Biopharmaceuticals, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+8,534 sh	—	—	8,534
2014-07-16	EPIRUS Biopharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	General Counsel	AAward	+99.4K sh	—	—	99,442

Recent filings

Accepted (ET)
Mar 94
Ticktin Robert0001613482-26-000002
SEC(opens sec.gov)
Jul 34
Ticktin Robert0001415889-25-019386
SEC(opens sec.gov)
May 314
EPIRUS Biopharmaceuticals, Inc.0001104659-16-124523
SEC(opens sec.gov)
Mar 14
EPIRUS Biopharmaceuticals, Inc.0001104659-16-101427
SEC(opens sec.gov)
Dec 224
EPIRUS Biopharmaceuticals, Inc.0001104659-15-086169
SEC(opens sec.gov)
Nov 34
EPIRUS Biopharmaceuticals, Inc.0001104659-15-075315
SEC(opens sec.gov)
Mar 24
EPIRUS Biopharmaceuticals, Inc.0001104659-15-015833
SEC(opens sec.gov)
Jul 174
EPIRUS Biopharmaceuticals, Inc.0001209191-14-048026
SEC(opens sec.gov)

Companies

Address

C/O PMV PHARMACEUTICALS, INC. 400 ALEXANDER PARK DRIVE, SUITE 301

PRINCETON, NJ, 08540